Home/Saverna Therapeutics/Kamal Azzaoui, PhD

KA

Kamal Azzaoui, PhD

CEO, Co-Founder

Saverna Therapeutics

Therapeutic Areas

Inflammation Autoimmune Diseases Cancer Infection

Saverna Therapeutics Pipeline

Drug	Indication	Phase
pre-miRNA targeting program	Undisclosed (within inflammation, autoimmune, cancer, or infection)	Pre-clinical

Leadership Team at Saverna Therapeutics

Marcel Blommers, PhD

CSO, Co-founder

Marjo Götte, PhD

Director Biology, Co-founder

Heinz Fretz, PhD

Director Chemistry

View full Saverna Therapeutics profile